Cargando…
Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
INTRODUCTION: On average, 19–23% of patients with acute myocardial infarction (MI) suffer from type 2 diabetes mellitus, which is newly diagnosed in a significant number of patients. Both classic carbohydrate metabolism and lipid metabolism may be promising diagnostic markers for insulin resistance...
Autores principales: | Barbarash, Olga, Gruzdeva, Olga, Uchasova, Evgenya, Belik, Ekaterina, Dyleva, Yulia, Karetnikova, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332457/ https://www.ncbi.nlm.nih.gov/pubmed/28261283 http://dx.doi.org/10.5114/aoms.2017.65240 |
Ejemplares similares
-
Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015) -
Insulin resistance and inflammation markers in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2013) -
Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2014) -
The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2016) -
Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga, et al.
Publicado: (2016)